论文信息 - The use of VP16 and cisplatin in the treatment of Merkel cell carcinoma.

The use of VP16 and cisplatin in the treatment of Merkel cell carcinoma.

A 70-year-old male with regionally recurrent Merkel cell cancer obtained a complete remission with three cycles of VP16 and cisplatin. His response was consolidated with local radiation therapy. Two additional patients have been reported to have responded to the same combination. Chemotherapy consisting of either cyclophosphamide, vincristine, and doxorubicin or VP16 and cisplatin should be considered in locally recurrent Merkel cell cancer.

[1] L. Einhorn,et al. Cisplatin plus etoposide in small cell lung cancer. , 1988, Seminars in oncology.

[2] W. Grosh,et al. Disseminated Merkel Cell Tumor Treatment with Systemic Chemotherapy , 1987, American journal of clinical oncology.

[3] R. Heelan,et al. Phase II trial of etoposide in APUD tumors. , 1987, Cancer treatment reports.

[4] M. Shiu,et al. Trabecular (merkel cell) carcinoma of the skin. Treatment of primary, recurrent, and metastatic disease , 1986, Cancer.

[5] W. T. Miller,et al. Recurrence‐free survival time for surgically treated soft tissue sarcoma patients. Multivariate analysis of five prognostic factors , 1986, Cancer.

[6] J. Bennett,et al. Chemotherapy for metastatic merkel cell carcinoma , 1985, Cancer.

[7] J. Hainsworth,et al. High-dose etoposide (VP-16) in small-cell lung cancer. , 1985, Seminars in oncology.

[8] Laster Wr,et al. cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice. , 1979 .

[9] C. Toker,et al. Trabecular carcinoma of the skin. An ultrastructural study , 1978, Cancer.

[10] C. Toker. Trabecular carcinoma of the skin. , 1972, Archives of dermatology.